|
시장보고서
상품코드
2102038
고처리량 공정 개발 시장 규모, 점유율, 성장 분석 : 기술별, 제품별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)High Throughput Process Development Market Size, Share, and Growth Analysis, By Technology (Automated High-Throughput Experimentation, Parallel Bioprocessing Systems), By Product, By Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 고처리량 공정 개발(HTPD) 시장 규모는 2024년에 13억 8,000만 달러로 평가되었으며, 2025년 15억 4,000만 달러에서 2033년까지 25억 6,000만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 11.85%로 성장할 것으로 전망됩니다.
세계 고처리량 공정 개발(HTPD) 시장은 다수의 조건을 동시에 시험할 수 있게함으로써 제약 및 생명공학 제조를 강화하는 방향으로 진화하고 있으며, 이를 통해 의약품 개발의 신속화와 비용 절감이라는 요구에 부응하고 있습니다. 최근의 기술 혁신으로 시장 동향은 기본적인 로봇 시스템에서 첨단 AI 기반 플랫폼으로 전환되었으며, 분석 능력이 대폭 향상됨과 동시에 최적화에 소요되는 기간이 단축되었습니다. 이러한 성장은 데이터 중심의 신약 개발과 자동화의 통합에 크게 힘입어 효율적인 사이클과 고도화된 의사결정으로 이어지고 있습니다. 기계 학습 모델을 통한 수율 예측이 점점 더 보편화됨에 따라, 신뢰할 수 있는 데이터를 제공하는 고처리량 바이오리액터에 대한 수요가 증가하고 있으며, 모듈식이며 클라우드에 연결된 기술에 대한 투자가 촉진되고 있습니다. 그 결과, 이러한 변화는 속도를 중시하는 기업들에게 새로운 길을 열어주며, 시장에서 경쟁 우위를 창출하고 있습니다.
세계 고처리량 공정 개발 시장의 촉진요인
세계 고처리량 공정 개발 시장은 자동화 기술의 발전에 의해 크게 견인되고 있습니다. 이 기술은 실험 프로토콜의 신속한 실행을 가능하게 하는 동시에, 인적 오류를 최소화하고 다수의 샘플에 걸쳐 균일한 조건을 보장합니다. 이러한 업무 효율성 향상은 데이터 수집 및 분석 기간을 단축할 뿐만 아니라 자원 배분도 최적화합니다. 그 결과, 연구소는 처리 능력을 향상시킬 수 있게 되었으며, 이는 후보 화합물의 스크리닝 및 공정 최적화를 신속히 진행하고자 하는 제약 회사 및 생명공학 기업에게 매력적인 요소로 작용하고 있습니다. 그 결과, 원활한 자동화를 지원하는 통합 소프트웨어 및 로봇 솔루션을 제공하는 플랫폼에 대한 수요가 전 세계적으로 꾸준히 증가하고 있습니다.
세계 고처리량 공정 개발 시장의 제약요인
세계 고처리량 공정 개발 시장은 주로 장비, 소프트웨어 라이선스 및 전문 인프라에 필요한 막대한 초기 투자로 인해 현저한 제약에 직면해 있습니다. 기업들은 막대한 자금을 할당해야 하며, 특히 예산이 제한된 중소기업의 경우 이것이 도입을 가로막는 요인이 될 수 있습니다. 이러한 자금적 장벽으로 인해 기업들은 투자 수익률(ROI)을 철저히 평가하게 되며, 이로 인해 프로젝트 계획 주기가 장기화될 우려가 있습니다. 또한, 비즈니스 타당성을 명확히 입증할 때까지 구매 결정이 미뤄질 가능성도 있습니다. 그 결과, 운영상의 이점을 얻기 전에 막대한 설비 투자가 필요하기 때문에 시장 성장이 억제되고 있습니다.
세계 고처리량 공정 개발 시장 동향
세계 고처리량 공정 개발 시장에서는 AI를 활용한 기술 통합을 향한 뚜렷한 동향이 나타나고 있습니다. 기업들은 실험 설계의 효율화, 데이터 해석의 자동화, 예측 모델링 강화를 위해 고처리량 플랫폼 내에서 인공지능 알고리즘의 도입을 점점 더 확대하고 있습니다. 기계 학습을 활용하여 정확한 매개변수 선정 및 패턴 인식을 수행함으로써, 기업들은 바이오의약품 및 저분자 의약품 개발 과정에서 사이클 타임을 대폭 단축하고 재현성을 높일 수 있습니다. 이러한 변화는 최적의 공정 조건을 신속하게 파악할 수 있게 할 뿐만 아니라, 실시간 의사결정 능력을 촉진하고, 개발 활동을 보다 광범위한 디지털 전환 목표와 조화시키며, 신약 개발 분야에서 높아지는 효율성과 속도에 대한 수요에 최적화된 대응을 가능하게 합니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 고처리량 공정 개발 시장 규모 : 기술별
세계의 고처리량 공정 개발 시장 규모 : 제품별
세계의 고처리량 공정 개발 시장 규모 : 용도별
세계의 고처리량 공정 개발 시장 규모 : 최종사용자별
세계의 고처리량 공정 개발 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.08.03Global High Throughput Process Development Market size was valued at USD 1.38 Billion in 2024 and is poised to grow from USD 1.54 Billion in 2025 to USD 2.56 Billion by 2033, growing at a CAGR of 11.85% during the forecast period (2026-2033).
The global high-throughput process development (HTPD) market is evolving to enhance pharmaceutical and biotech manufacturing by enabling the simultaneous testing of numerous conditions, thus addressing the need for expedited drug development and cost containment. Recent innovations have shifted the landscape from basic robotic systems to sophisticated AI-driven platforms, significantly improving analytics and reducing optimization timelines. This growth is largely driven by the integration of data-centric drug discovery with automation, leading to efficient cycles and enhanced decision-making. As machine-learning models increasingly predict yields, there is a rising demand for high-throughput bioreactors that yield reliable data, prompting investments in modular, cloud-connected technologies. Consequently, this transformation opens new avenues for businesses that prioritize speed, creating a competitive edge in the market.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global High Throughput Process Development market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global High Throughput Process Development Market Segments Analysis
Global high throughput process development market is segmented by technology, product, application, end user and region. Based on technology, the market is segmented into Automated High-Throughput Experimentation (HTE), Parallel Bioprocessing Systems, Microfluidics-Based Process Development, Robotics & Laboratory Automation and Process Analytical Technology (PAT) Integration. Based on product, the market is segmented into Instruments & Automated Systems, Consumables & Reagents, Software & Data Analytics and Services. Based on application, the market is segmented into Cell Line Development, Upstream Process Development, Downstream Process Development and Formulation & Process Optimization. Based on end user, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs) and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global High Throughput Process Development Market
The Global High Throughput Process Development market is significantly driven by the advancements in automation technologies, which facilitate the swift implementation of experimental protocols while minimizing human error and ensuring uniform conditions across numerous samples. This enhancement in operational efficiency not only accelerates the timelines for data capture and analysis but also optimizes the allocation of resources. As a result, laboratories are able to increase their throughput capabilities, which proves attractive to pharmaceutical and biotech companies eager to speed up candidate screening and process optimization. Consequently, the demand for platforms that provide integrated software and robotics solutions to support seamless automation is consistently rising on a global scale.
Restraints in the Global High Throughput Process Development Market
The global market for high-throughput process development faces notable constraints primarily due to the heavy initial investment required for equipment, software licenses, and specialized infrastructure. Organizations need to allocate significant financial resources, which can deter adoption, especially among small to medium-sized enterprises with limited budgets. This financial hurdle can lead to extended project planning cycles as companies thoroughly assess their return on investment and may result in delays in purchasing decisions until they can clearly justify the business case. As a result, the growth of the market is tempered by the necessity for considerable capital investment before any operational advantages are achieved.
Market Trends of the Global High Throughput Process Development Market
The Global High Throughput Process Development market is witnessing a significant trend towards the integration of AI-enhanced technologies. Companies are increasingly adopting artificial intelligence algorithms within their high-throughput platforms to streamline experimental design, automate data interpretation, and enhance predictive modeling. By leveraging machine learning for precise parameter selection and pattern recognition, organizations can significantly shorten cycle times and enhance reproducibility in both biologics and small-molecule development. This transformation not only facilitates rapid identification of optimal process conditions but also fosters real-time decision-making capabilities, aligning development efforts with broader digital transformation objectives and optimizing responses to the increasing demand for efficiency and speed in drug discovery.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global High Throughput Process Development Market Size by Technology & CAGR (2026-2033)
- Market Overview
- Automated High-Throughput Experimentation (HTE)
- Parallel Bioprocessing Systems
- Microfluidics-Based Process Development
- Robotics & Laboratory Automation
- Process Analytical Technology (PAT) Integration
Global High Throughput Process Development Market Size by Product & CAGR (2026-2033)
- Market Overview
- Instruments & Automated Systems
- Consumables & Reagents
- Software & Data Analytics
- Services
Global High Throughput Process Development Market Size by Application & CAGR (2026-2033)
- Market Overview
- Cell Line Development
- Upstream Process Development
- Downstream Process Development
- Formulation & Process Optimization
Global High Throughput Process Development Market Size by End User & CAGR (2026-2033)
- Market Overview
- Biopharmaceutical & Pharmaceutical Companies
- Contract Research Organizations (CROs)
- Contract Development and Manufacturing Organizations (CDMOs)
- Academic & Research Institutes
Global High Throughput Process Development Market Size & CAGR (2026-2033)
- North America (Technology, Product, Application, End User)
- US
- Canada
- Europe (Technology, Product, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Technology, Product, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Technology, Product, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Technology, Product, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tecan Group Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eppendorf SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hamilton Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE HealthCare Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Repligen Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- WuXi Biologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Group AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Catalent Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Charles River Laboratories International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- INTEGRA Biosciences AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gilson Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Opentrons Labworks Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hudson Robotics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
